SMOOCH - Small Volume Challenges to Predict Volume Responsiveness: Prospective Interventional Study

NCT ID: NCT01227304

Last Updated: 2010-10-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-07-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

* test for volume responsiveness
* PiCCO-guided infusion over a pre-defined period of time

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prediction of Volume Responsiveness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Test of volume responsiveness using crystalloids

Group Type EXPERIMENTAL

PiCCO-parameter-guided volume challenge

Intervention Type DEVICE

Infusion of 7ml/kg crystalloid over 30 minutes, Performing transpulmonary thermodilutions after 0min, 15min and 30min. Recording of pulse contour cardiac index, heart rate and mean arterial pressure after 5, 10, 15, 20, 25 and 30min. Catecholamines are kept stable over the 30min period.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PiCCO-parameter-guided volume challenge

Infusion of 7ml/kg crystalloid over 30 minutes, Performing transpulmonary thermodilutions after 0min, 15min and 30min. Recording of pulse contour cardiac index, heart rate and mean arterial pressure after 5, 10, 15, 20, 25 and 30min. Catecholamines are kept stable over the 30min period.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients are equipped with PiCCO monitoring independently to the study.
* One criteria of decreased usefulness of the parameters of preload/volume responsiveness available using the PiCCO device:

1. Femoral access of the central venous catheter precluding application of the normal ranges of global enddiastolic volume index and central venous pressure.
2. Absence of sinus rhythm and/or controlled ventilation precluding the use of stroke volume variation.
3. Evidence of increased intraabdominal pressure which is known to further reduce the usefulness of central venous pressure.
4. Contradictory suggestions by stroke volume variation and global enddiastolic volume index.
5. Intolerance of passive leg raising.
6. Absence of therapeutic alternatives to volume resuscitation.

Exclusion Criteria

* Extravascular volume-over plus: global enddiastolic volume index \> 1000ml/sqm
* Pulmonary edema: extravascular lungwater index \> 20ml/kg
* Cardiogenic shock without volume deficiency (cardiac index \<2L/min; global enddiastolic volume index \> 850ml/sqm)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Technical University of Munich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Klinikumr rechts der Isar

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

2nd Medical Department, Klinikum rechts der Isar

Munich, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Wolfgang Huber, MD

Role: primary

+49-89-4140-2214

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SMOOCH-1

Identifier Type: -

Identifier Source: org_study_id